| __timestamp | Pfizer Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 9577000000 | 5758000 |
| Thursday, January 1, 2015 | 9648000000 | 8423000 |
| Friday, January 1, 2016 | 12329000000 | 11986000 |
| Sunday, January 1, 2017 | 11240000000 | 15215000 |
| Monday, January 1, 2018 | 11248000000 | 15356000 |
| Tuesday, January 1, 2019 | 10219000000 | 16660000 |
| Wednesday, January 1, 2020 | 8692000000 | 52459000 |
| Friday, January 1, 2021 | 30821000000 | 75061000 |
| Saturday, January 1, 2022 | 34344000000 | 87221000 |
| Sunday, January 1, 2023 | 29687000000 | 83779000 |
| Monday, January 1, 2024 | 17851000000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical industry, understanding cost dynamics is crucial. Pfizer Inc., a global leader, and Supernus Pharmaceuticals, Inc., a niche player, offer a fascinating contrast in cost of revenue trends from 2014 to 2023. Pfizer's cost of revenue surged by over 250% from 2014 to 2022, peaking at approximately $34 billion in 2022, reflecting its expansive operations and product portfolio. In contrast, Supernus Pharmaceuticals, Inc. experienced a more modest increase, with costs rising by about 1,400% over the same period, reaching nearly $87 million in 2022. This stark difference highlights the scale and scope of operations between a pharmaceutical giant and a specialized firm. The data underscores the importance of strategic cost management in maintaining competitive advantage in the pharmaceutical sector.
Cost of Revenue Comparison: AstraZeneca PLC vs Pfizer Inc.
Cost of Revenue Trends: Pfizer Inc. vs United Therapeutics Corporation
Cost Insights: Breaking Down Pfizer Inc. and Grifols, S.A.'s Expenses
Analyzing Cost of Revenue: Pfizer Inc. and MorphoSys AG
Cost of Revenue Trends: Pfizer Inc. vs Agios Pharmaceuticals, Inc.
Analyzing Cost of Revenue: Pfizer Inc. and Celldex Therapeutics, Inc.
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Supernus Pharmaceuticals, Inc.
Cost Insights: Breaking Down Pharming Group N.V. and Supernus Pharmaceuticals, Inc.'s Expenses
Corcept Therapeutics Incorporated vs Supernus Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Cytokinetics, Incorporated and Supernus Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Supernus Pharmaceuticals, Inc. vs Wave Life Sciences Ltd.
Comparing Cost of Revenue Efficiency: Supernus Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.